• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Dispute simmers over who first shared SARS-CoV-2’s genome

Mary Wilson

Well-known member
Scientists suggest GISAID, a virus sequence database, is rewriting pandemic history

29 MAR 2023
2:35 PM
BY MARTIN ENSERINK

When GISAID, the widely used database for influenza and SARS-CoV-2 genomes, issued a statement last week about a set of controversial sequences from the Huanan Seafood Wholesale Market in Wuhan, China, the release explained by way of background that the repository was “an essential contributor to global health” trusted by thousands of data contributors from 215 nations and territories. But GISAID also included a claim that has been puzzling and infuriating some virologists for 3 years: It was the place where the first SARS-CoV-2 genomes were publicly shared, on 10 January 2020.

That claim challenges contemporaneous news and social media accounts, the memories of many researchers contacted by Science, and non-GISAID records that all indicate the first sequence was made available through virological.org, a forum where scientists share and discuss information, early on 11 January in Europe, which was the evening of 10 January in the United States. It had been submitted by Edward Holmes, an evolutionary biologist and virologist at the University of Sydney who had received the sequence from Zhang Yong-Zhen, a virologist at Fudan University. GISAID, various information sources suggest, didn’t actually make its first genomes of the new coronavirus public until 12 January 2020.

“I am very surprised” at GISAID’s claims, Zhang wrote in an email to Science. “I could not understand why some people attempted to rewrite the history.” ...

https://www.science.org/content/article/dispute-simmers-over-who-first-shared-sars-cov-2-s-genome
 
First shared SARS-CoV-2 genome: GISAID vs virological.org - The Lancet

Published: April 25, 2023

DOI:https://doi.org/10.1016/S2666-5247(23)00133-7

Talha Burki

The Global Initiative on Sharing All Influenza Data (GISAID) has been a vital resource during the COVID-19 pandemic. About 15 million SARS-CoV-2 sequences have been uploaded to the GISAID database, enabling researchers to monitor the emergence and spread of variants such as alpha, delta, and omicron, as well as undertake studies aimed at developing vaccines and therapeutics. None of which is under dispute. But GISAID's contention that it was the first to publicly share the SARS-CoV-2 genome has sparked controversy. ...

The Lancet Microbe was unable to find contemporary evidence to verify GISAID's claims. There is no mention of a GISAID release of the SARS-CoV-2 genome among the entries on FluTrackers.com for Jan 10, 2020, though the virological.org genome is flagged soon after its publication. The only tweet to include the words “GISAID” and “genome” on Jan 9–12, 2020, is the one quoted above from WHO.​ ...

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00133-7/fulltext

 
Back
Top